Results 61 to 70 of about 13,067 (212)
Emerging and under-recognized Chagas cardiomyopathy in non-endemic countries [PDF]
Due to recent population emigration movements, an epidemic of Chagas disease is currently menacing most developed countries. The authors report the case of a 53-year-old Brazilian woman living in Europe for the last 10 years who developed heart failure ...
Cortez, J +7 more
core +1 more source
Bufalin‐Induced Epithelial‐to‐Mesenchymal Transition in Kidney Epithelial Cells
ABSTRACT The kidney plays a central role in fluid, electrolyte, and blood pressure regulation, processes tightly coupled to Na⁺/K⁺‐ATPase activity. Beyond its canonical transport function, Na⁺/K⁺‐ATPase also acts as a signaling receptor for cardiotonic steroids (CTSs) such as bufalin, which have been implicated in fibrosis and epithelial‐to‐mesenchymal
Gabriela Morais de Oliveira Barros +3 more
wiley +1 more source
Chagas cardiomyopathy (ChCM) is a severe consequence of Trypanosoma cruzi infection and has a range of electrocardiographic (ECG) and echocardiographic (ECHO) manifestations. There is a need for a standard and parsimonious research cardiac end point that
Lewis F. Buss +6 more
doaj +1 more source
Evaluation of VDR gene polymorphisms in Trypanosoma cruzi infection and chronic Chagasic cardiomyopathy [PDF]
Vitamin D is an important modulator of the immune response. It acts over several immune cell types where the Vitamin D receptor (VDR) is expressed.
Carmona, F.D. +3 more
core +2 more sources
Preoperative CT and 3D reconstruction demonstrating an inferior left ventricular aneurysm in a patient with a retrosternal gastric conduit, highlighting the rationale for choosing a left mini‐thoracotomy approach. ABSTRACT In patients with prior esophagectomy and retrosternal gastric conduit, conventional sternotomy may be hazardous.
Junya Kitaura +2 more
wiley +1 more source
Ex vivo T-lymphocyte chemokine receptor phenotypes in patients with chronic Chagas disease
INTRODUCTION: Elucidating the molecules involved in the inflammatory process of chronic Chagas disease may allow identification of treatment targets.
Matheus Barbosa de Miranda +5 more
doaj +1 more source
Chagas disease continues to be a significant public health problem, as ca. 10 million people are still infected with T. cruzi in Latin America. Decades after primary infection, 30% of individuals can develop a form of chronic inflammatory cardiomyopathy ...
Angelina M.B. Bilate, Edecio Cunha-Neto
doaj +1 more source
The burden of congenital Chagas disease and implementation of molecular diagnostic tools in Latin America [PDF]
It is estimated that between 8000 and 15 000 Trypanosoma cruzi infected babies are born every year to infected mothers in Chagas disease endemic countries. Currently, poor access to and performance of the current diagnostic algorithm, based on microscopy
Cruz, Israel +7 more
core +1 more source
The novel EPI‐VT‐Score accurately predicts the need for epicardial VT ablation using simple clinical, echocardiographic and ECG variables, optimizing patient selection and procedural outcomes. ABSTRACT Background Epicardial ventricular tachycardia (VT) ablation is a therapeutic option for drug‐refractory VT, particularly when endocardial ablation fails
Moneeb Khalaph +17 more
wiley +1 more source
Enhancing patient care: a multimodality strategy for dilated cardiomyopathy in Chagas disease [PDF]
Chagas disease is a systemic illness characterized by acute and chronic phases. If untreated, it can lead to dysfunction of vital organs, notably the heart, ultimately resulting in heart failure.
Luigy Vasquez-Yeng +8 more
doaj +1 more source

